Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Virobay
1360 Willow Road, Suite 100
Menlo Park, CA 94025
Phone: 650-833-5700
http://www.virobayinc.com/index.php

Virobay is focused on the development and commercialization of novel drugs through the utilization of small molecule cysteine proteases inhibitors, a diverse class of enzyme proteases, for a variety of conditions, including neuropathic pain, autoimmune diseases and fibrosis. The foundation of Virobay's proprietary cathepsin platform and the Virobay management team were spun-out from Celera Genomics, which was then a leader in cathepsin research. Virobay's clinical pipeline currently includes product candidates in neuropathic pain, dermatology, autoimmune disease and fibrosis.

Key Contact
Name
Dr. Robert Booth
Title
CEO
Funding Events

Date
Amount
Type
Investors
07/16/14 $8,000,000 Series B AbbVie Biotech Ventures
Alta Partners
Perceptive Advisors
Sutter Hill Ventures
TPG Biotech


Featured Reading